17 studies found for:    bacterial vaginosis | NIH
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence
Condition: Bacterial Vaginosis
Interventions: Other: hygienic information plus 62% ethyl alcohol in emollient gel;   Other: hygienic information
2 Completed Bacterial Vaginosis Home Screening to Prevent STDs
Condition: Bacterial Vaginosis
Intervention: Drug: Metronidazole
3 Completed
Has Results
Treatment of Bacterial Vaginosis (BV) With Tinidazole
Condition: Bacterial Vaginosis
Intervention: Drug: tinidazole, metronidazole
4 Recruiting Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis
Condition: Bacterial Vaginosis
Interventions: Drug: 750 mg metronidazole/ 200 mg miconazole vaginal suppository;   Drug: Standard of care
5 Completed
Has Results
Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women
Conditions: Bacterial Vaginosis;   Candidiasis;   Trichomoniasis
Interventions: Drug: Neo-Penotran® Forte (active ingredient Metronidazole & Miconazole Nitrate);   Drug: Placebo
6 Not yet recruiting Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity
Conditions: Bacterial Vaginosis,;   HIV
Intervention: Drug: NuvaRing
7 Terminated
Has Results
Empiric Therapy of Mucopurulent Cervicitis (MPC)
Conditions: Vaginitis Bacterial;   Cervicitis
Interventions: Other: Placebo;   Drug: Azithromycin;   Drug: Cefixime
8 Completed Longitudinal Study of Vaginal Flora
Condition: Vaginal Flora
Intervention:
9 Completed Perinatal Infections in Pakistan
Conditions: Bacterial Vaginosis;   Fetal Membranes, Premature Rupture;   Chorioamnionitis;   Pregnancy
Intervention:
10 Not yet recruiting Effects of a Vaginal Contraceptive Ring on Vaginal Microbiota and Local Immunity
Condition: Bacterial Vaginosis
Intervention: Drug: NuvaRing
11 Unknown  Maternal Genitourinary Infections and Adverse Perinatal Outcomes
Condition: Maternal Infection Affecting Newborn
Intervention: Other: Screening treatment and referral
12 Completed BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women
Condition: HIV Infections
Interventions: Drug: BufferGel;   Drug: PRO 2000/5 Gel;   Drug: Placebo gel
13 Completed Long-term Iron Supplements and Malaria Risk in Early Pregnancy: a Randomized Controlled Trial
Condition: Malaria
Interventions: Dietary Supplement: Folic Acid;   Dietary Supplement: Folic Acid and Iron
14 Completed Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463
Condition: Vaginal Infection
Interventions: Drug: TOL-463 Vaginal ovule;   Drug: TOL-463 Vaginal gel
15 Unknown  Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-be
Conditions: Pregnancy;   Pregnancy Complications
Intervention:
16 Active, not recruiting The Contraceptive Choice Project
Conditions: Unintended Pregnancy;   Teen Births;   Abortion;   Contraception
Intervention:
17 Completed Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission
Condition: HIV Infections
Interventions: Drug: Erythromycin;   Drug: Nevirapine;   Drug: Ampicillin sodium;   Drug: Metronidazole

Indicates status has not been verified in more than two years